Clinical Trial Update: Efficacy and Safety of the CorVad Percutaneous Ventricular Assist System in Cardiogenic Shock [NA]

View source ↗

Summary

This clinical trial update states that the CorVad Percutaneous Ventricular Assist System is currently recruiting to evaluate its efficacy and safety in cardioge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Snippet

Sponsor: Shenzhen Core Medical Technology CO.,LTD. | Conditions: Cardiogenic Shock | NA | Status: RECRUITING